Dermata Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-11
- Dermata Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$20.63K.
- Dermata Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$445.64K, a 410.14% decline year-over-year.
- Dermata Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $521.75K, a 288.15% increase year-over-year.
- Dermata Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $45.30K, a 90.46% decline year-over-year.
- Dermata Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $14.85K, a 96.35% decline from fiscal 2024.
- Dermata Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $407.19K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$20.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$466.27K 10-Q · filed 2026-08-11 | $55.48K derived: sum of 3 quarters · filed 2026-08-11 | $100.78K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$445.64K 10-Q · filed 2026-05-13 | $76.11K derived: sum of 2 quarters · filed 2026-05-13 | $121.42K derived: sum of 3 quarters · filed 2026-05-13 | -$574.48K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $521.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $567.06K derived: sum of 2 quarters · filed 2026-03-26 | -$128.84K derived: sum of 3 quarters · filed 2026-08-11 | $14.85K 10-K · filed 2026-03-26 |
| 2025-09-30 | $45.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$650.59K derived: sum of 2 quarters · filed 2026-08-11 | -$506.90K 10-Q · filed 2025-11-14 | -$372.48K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$695.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$552.21K 10-Q · filed 2026-08-11 | -$417.78K derived: sum of 3 quarters · filed 2026-08-11 | $56.93K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $143.69K 10-Q · filed 2026-05-13 | $278.11K derived: sum of 2 quarters · filed 2026-05-13 | $752.82K derived: sum of 3 quarters · filed 2026-05-13 | $759.25K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $134.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $609.13K derived: sum of 2 quarters · filed 2026-03-26 | $615.56K derived: sum of 3 quarters · filed 2026-03-26 | $407.19K 10-K · filed 2026-03-26 |
| 2024-09-30 | $474.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $481.14K derived: sum of 2 quarters · filed 2025-11-14 | $272.77K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $6.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$201.94K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$208.37K 10-Q · filed 2025-05-14 |